Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
JBI-778 in Recurrent Glioma: NCT07755397 Clinical Landscape Report 2026
16 September 2026
NCT07755397 clinical landscape for Recurrent Glioma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia with FLT3/ITD Mutation: NCT07755202 Clinical Landscape Report 2026
16 September 2026
NCT07755202 clinical landscape for Acute Myeloid Leukemia with FLT3/ITD Mutation: endpoints, sponsor, phase, geography, readouts, asset context and developme…
9 min read
Paclitaxel in Resectable Lung Non-Small Cell Carcinoma: NCT07754812 Clinical Landscape Report 2026
16 September 2026
NCT07754812 clinical landscape for Resectable Lung Non-Small Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
9 min read
HS-10504 in metastatic non-small cell lung cancer: NCT07754123 Clinical Landscape Report 2026
16 September 2026
NCT07754123 clinical landscape for metastatic non-small cell lung cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07754799 Clinical Landscape Report 2026
16 September 2026
NCT07754799 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Elecoglipron in Chronic Kidney Diseases: NCT07753993 Clinical Landscape Report 2026
16 September 2026
NCT07753993 clinical landscape for Chronic Kidney Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Belimumab in Rheumatic Diseases: ISRCTN76569516 Clinical Landscape Report 2026
16 September 2026
ISRCTN76569516 clinical landscape for Rheumatic Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SL-325 in Crohn Disease: NCT07753850 Clinical Landscape Report 2026
16 September 2026
NCT07753850 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Florquinitau F18 in Alzheimer Disease: NCT07758660 Clinical Landscape Report 2026
16 September 2026
NCT07758660 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Afabicin diolamine in Renal Insufficiency: NCT07758608 Clinical Landscape Report 2026
16 September 2026
NCT07758608 clinical landscape for Renal Insufficiency: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ATV-Abeta(Denali Therapeutics) in Alzheimer Disease: NCT07758595 Clinical Landscape Report 2026
16 September 2026
NCT07758595 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SHR-7590 in Colitis, Ulcerative: NCT07758101 Clinical Landscape Report 2026
16 September 2026
NCT07758101 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.